Literature DB >> 16336965

Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis.

Lauren Crigler1, Rebecca C Robey, Amy Asawachaicharn, Dina Gaupp, Donald G Phinney.   

Abstract

Mesenchymal stem cells (MSCs) transplanted at sites of nerve injury are thought to promote functional recovery by producing trophic factors that induce survival and regeneration of host neurons. To evaluate this phenomenon further, we quantified in human MSCs neurotrophin expression levels and their effects on neuronal cell survival and neuritogenesis. Screening a human MSC cDNA library revealed expressed transcripts encoding BDNF and beta-NGF but not NT-3 and NT-4. Immunostaining demonstrated that BDNF and beta-NGF proteins were restricted to specific MSC subpopulations, which was confirmed by ELISA analysis of 56 separate subclones. Using a co-culture assay, we also demonstrated that BDNF expression levels correlated with the ability of MSC populations or subclones to induce survival and neurite outgrowth in the SH-SY5Y neuroblastoma cell line. However, these MSC-induced effects were only partially inhibited by a neutralizing anti-BDNF antibody. MSCs were also shown to promote neurite outgrowth within dorsal root ganglion explants despite secreting 25-fold lower level of beta-NGF required exogenously to produce a similar effect. Interrogation of the human MSC transcriptome identified expressed mRNAs encoding various neurite-inducing factors, axon guidance and neural cell adhesion molecules. Moreover, a subset of these transcripts was shown to correlate with BDNF expression in MSC subclones. Collectively, these studies reveal the existence of MSC subpopulations that co-express neurotrophins and other potent neuro-regulatory molecules, which contribute to MSC-induced effects on neuronal cell survival and nerve regeneration. These subpopulations may represent more potent vectors for treating a variety of neurological disorders.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16336965     DOI: 10.1016/j.expneurol.2005.10.029

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  183 in total

1.  Neural markers expression in rat bone marrow mesenchymal stem cell cultures treated with neurosteroids.

Authors:  Daniela Bronzi; Vincenzo Bramanti; Daniele Tomassoni; Floriana Laureanti; Sonia Grasso; Guido Li Volsi; Roberto Avola
Journal:  Neurochem Res       Date:  2010-10-13       Impact factor: 3.996

Review 2.  Modern stem cell therapy: approach to disease.

Authors:  Mateja Zemljic; Bozena Pejkovic; Ivan Krajnc; Lidija Kocbek
Journal:  Wien Klin Wochenschr       Date:  2015-12-10       Impact factor: 1.704

Review 3.  Recent therapeutic strategies for spinal cord injury treatment: possible role of stem cells.

Authors:  D Garbossa; M Boido; M Fontanella; C Fronda; A Ducati; A Vercelli
Journal:  Neurosurg Rev       Date:  2012-04-27       Impact factor: 3.042

Review 4.  Genetic modification of stem cells for transplantation.

Authors:  M Ian Phillips; Yao Liang Tang
Journal:  Adv Drug Deliv Rev       Date:  2007-10-11       Impact factor: 15.470

5.  Effect of transplantation of bone marrow-derived mesenchymal stem cells on mice infected with prions.

Authors:  Chang-Hyun Song; Osamu Honmou; Natsuo Ohsawa; Kiminori Nakamura; Hirofumi Hamada; Hidefumi Furuoka; Rie Hasebe; Motohiro Horiuchi
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

Review 6.  Stem cell paracrine actions and tissue regeneration.

Authors:  Priya R Baraniak; Todd C McDevitt
Journal:  Regen Med       Date:  2010-01       Impact factor: 3.806

Review 7.  Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration?

Authors:  Fábio G Teixeira; Miguel M Carvalho; Nuno Sousa; António J Salgado
Journal:  Cell Mol Life Sci       Date:  2013-03-01       Impact factor: 9.261

8.  Comparison of the efficiencies of three neural induction protocols in human adipose stromal cells.

Authors:  Dong-Xiang Qian; Hong-Tian Zhang; Xu Ma; Xiao-Dan Jiang; Ru-Xiang Xu
Journal:  Neurochem Res       Date:  2009-12-04       Impact factor: 3.996

Review 9.  Use of genetically modified mesenchymal stem cells to treat neurodegenerative diseases.

Authors:  Robert D Wyse; Gary L Dunbar; Julien Rossignol
Journal:  Int J Mol Sci       Date:  2014-01-23       Impact factor: 5.923

10.  Localized delivery of brain-derived neurotrophic factor-expressing mesenchymal stem cells enhances functional recovery following cervical spinal cord injury.

Authors:  Heather M Gransee; Wen-Zhi Zhan; Gary C Sieck; Carlos B Mantilla
Journal:  J Neurotrauma       Date:  2014-12-10       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.